2014 Publication list

2014 Publication list

1. Aoe, K., N. Takigawa, K. Hotta, T. Maeda, D. Kishino, N. Nogami, M. Tabata, S. Harita, T. Okada, T. Kubo, S. Hosokawa, K. Fujiwara, K. Gemba, M. Yasugi, T. Kozuki, Y. Kato, K. Katsui, S. Kanazawa, H. Ueoka, M. Tanimoto, and K. Kiura. 2014. A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801. Eur J Cancer 50: 2783-2790.
2. Fujimoto, N., K. Ohnuma, K. Aoe, O. Hosono, T. Yamada, T. Kishimoto, and C. Morimoto. 2014. Clinical significance of soluble CD26 in malignant pleural mesothelioma. PLoS One 9: e115647.
3. Hotta, K., K. Kiura, M. Tabata, N. Takigawa, M. Tanimoto, and H. Ueoka. 2014. A survey of Japanese thoracic oncologists’ perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer. Chest 146: e222-225.
4. Solomon, B. J., T. Mok, D. W. Kim, Y. L. Wu, K. Nakagawa, T. Mekhail, E. Felip, F. Cappuzzo, J. Paolini, T. Usari, S. Iyer, A. Reisman, K. D. Wilner, J. Tursi, F. Blackhall, and PROFILE 1014 Investigators (Aoe, K. contributed). 2014. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371: 2167-2177.
5. Ueda, K., M. Hayashi, N. Tanaka, T. Tanaka, and K. Hamano. 2014. Long-term pulmonary function after major lung resection. Gen Thorac Cardiovasc Surg 62: 24-30.
6. Yamamoto, J., K. Ohnuma, R. Hatano, T. Okamoto, E. Komiya, H. Yamazaki, S. Iwata, N. H. Dang, K. Aoe, T. Kishimoto, T. Yamada, and C. Morimoto. 2014. Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma. Br J Cancer 110: 2232-2245.
7. Ichihara, E., K. Hotta, N. Nogami, S. Kuyama, D. Kishino, M. Fujii, T. Kozuki, M. Tabata, D. Harada, K. Chikamori, K. Aoe, H. Ueoka, S. Hosokawa, A. Bessho, A. Hisamoto-Sato, T. Kubo, I. Oze, N. Takigawa, M. Tanimoto, and K. Kiura. 2015. Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001. J Thorac Oncol 10: 486-491.
8. Iwatsuka, K., K. Inada, H. Ueoka, T. Otsuka, M. Maeda, M. Yamaguchi, and S. Yasueda. 2015. Effect of textured eye drop bottles on the photostability of pranoprofen 0.1% ophthalmic solution. Drug Dev Ind Pharm 41: 1526-1531.
9. Nogami, N., N. Takigawa, K. Hotta, Y. Segawa, Y. Kato, T. Kozuki, I. Oze, D. Kishino, K. Aoe, H. Ueoka, S. Kuyama, S. Harita, T. Okada, S. Hosokawa, K. Inoue, K. Gemba, T. Shibayama, M. Tabata, M. Takemoto, S. Kanazawa, M. Tanimoto, and K. Kiura. 2015. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501. Lung Cancer 87: 141-147.
10. Hichiya, H, Mimura, Y., Hanioka, M. 2014. Evaluation of oral antidepressant drugs for adaptation to the simple suspension method. J Young Pharmacists 6: 56-60.
11. 厚東涼子.、入院時から取り組む患者の退院「チームで取り組んだ退院支援」　看護実践の科学　Vol.39(8), July, 2014
12. 藤本伸一、青江啓介、大泉聡史、上月稔幸、亀井敏昭、三浦溥太郎、井内康輝、岸本卓巳．胸膜中皮腫を中心とした胸水ヒアルロン酸に関する症例調査．肺癌 2014; 54(6): 767-771
13. 吉田久美子、松田英祐、田中俊樹、田尾裕之、林達朗、岡部和倫．完全胸腔鏡下に切除した特発性奇静脈瘤の2例．日本呼吸器外科学会誌　29巻1号101-105 2014年
14. 松久哲章、今日のがん薬物療法における薬薬連携を考える、週刊　薬事新報、第2859号、3,4頁、2014年
15. 吉田久美子、松田英祐、田中俊樹、田尾裕之、林達朗、岡部和倫．完全胸腔鏡下に切除した特発性奇静脈瘤の2例．日本呼吸器外科学会雑誌29巻1号（2015.1） p101-105
16. 青江啓介．スキル強化のための知識補充特集－肺がん．Oncology NURSE、日総研出版、名古屋、2015; 1・2月号: 18-23
17. 辛島隆司、長期人工呼吸管理における人工呼吸器の保守管理の現状と問題点-病院内-  Clinical Engineering vol.26 No.2 2015
18. 佐伯達矢、いつから?何を？どうする？ 呼吸療法士認定士受験ガイド Theme 3　さらにステップアップ！ 呼吸療法士認定士の知識が活かせる資格　「慢性呼吸器疾患看護認定看護師」呼吸器ケア Vol.13(1), Jan, 2015